ADITI MATHUR

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease CLIFTON, NJ NPI 1629255708

General Payments — all program years on this page

$2,432.38

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $703.29 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $703.2915

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $149.441
2021 $1,342.783
2022 $131.942
2023 $104.931
2024 $703.2915

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105577160 AstraZeneca Pharmaceuticals LP $118.71 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111646144 Amgen Inc. $17.00 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115779033 GlaxoSmithKline, LLC. $17.00 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116041367 GlaxoSmithKline, LLC. $16.32 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116462238 GlaxoSmithKline, LLC. $18.96 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116621333 GlaxoSmithKline, LLC. $17.21 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118086324 Boehringer Ingelheim Pharmaceuticals, Inc. $16.56 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118086326 Boehringer Ingelheim Pharmaceuticals, Inc. $44.45 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118086328 Boehringer Ingelheim Pharmaceuticals, Inc. $124.11 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137631209 Takeda Pharmaceuticals U.S.A., Inc. $14.95 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137631211 Takeda Pharmaceuticals U.S.A., Inc. $16.33 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139686009 GENZYME CORPORATION $121.85 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139686061 GENZYME CORPORATION $124.98 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147295943 Mylan Specialty L.P. $15.91 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147377650 Mylan Specialty L.P. $18.95 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.